Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 279

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 279
---
 (Note 2)                             |     |   |  1,936,236 |   |
| Issuance of shares through conversion of convertible notes |     |   |  2,650,000 |   |
| Decrease in subscription receivable                        
 due to reduction of work by professionals (Note 1)         |     |   | (2,766,856 | ) |
| Business Combination (Note                                 
 3)                                                         |     |   | (6,028,690 | ) |
| Balance as at December 31, 2024                            |     | $ |    122,505 |   |
| Capitalized Subscription receivable (note 4)               |     |   |   (204,000 | ) |
| Issuance of shares through Equity Line of Credit (note 5)  |     |   |  9,401,940 |   |
| Issuance of share for business Combination (note 6)        |     |   |    257,500 |   |
| Balance as at June 30, 2025                                |     | $ |  9,577,945 |   |

Note 1: On January 10, 2023, the Company
issued 1,365 ordinary shares to professional party for consulting service of 10 years, increasing the additional paid-in capital by $812,300.
On December 4, 2023, the Company issued additional 3,450 shares to DoubleClick Services Limited for consulting service of 10 years, increasing
the additional paid-in capital by $2,054,556. During 2024, the service scope and duration were reduced and the service value was adjusted
accordingly pursuant to addendums to respective agreements

On November 21, 2024, the Company
entered into a Common Shares Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC (“White
Lion”) and a related Registration Rights Agreement (the “RRA”). Pursuant to the White Lion Purchase Agreement, the
Company has the right, but not the obligation, to require White Lion to purchase, within 36 months from the Agreement effective date
up to One Hundred Million Dollars ($100,000,000) in aggregate gross purchase price of newly issued Ordinary Shares, with an automatic
increase to Three Hundred Million Dollars ($300,000,000) upon any substantial M&A or Material Transaction (as defined in the White
L